Insider · CIK 0001862930

Janku Filip

Reports to the SEC for 1 company · BOSTON, MA

sec.gov

Transactions

Companies

Filings

CIK

0001862930

Forms 4 and 5

Insider transactions

25 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-30	GLUEMonte Rosa Therapeutics, Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+5,407 sh	$13.41	+$72.5K	66,019
2026-06-30	GLUEMonte Rosa Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−5,407 sh	$24.50	−$132K	60,612
2026-06-30	GLUEMonte Rosa Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−5,407 sh	—	—	81,093
2026-06-29	GLUEMonte Rosa Therapeutics, Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+6,000 sh	$7.56	+$45.4K	65,992
2026-06-29	GLUEMonte Rosa Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−6,000 sh	$22.95	−$138K	59,992
2026-06-29	GLUEMonte Rosa Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−6,000 sh	—	—	60,000
2026-06-24	GLUEMonte Rosa Therapeutics, Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+30K sh	$7.56	+$227K	89,992
2026-06-24	GLUEMonte Rosa Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−30K sh	$21.42	−$643K	59,992
2026-06-24	GLUEMonte Rosa Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−30K sh	—	—	66,000
2026-06-23	GLUEMonte Rosa Therapeutics, Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+6,000 sh	$7.56	+$45.4K	71,837
2026-06-23	GLUEMonte Rosa Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−11.8K sh	$20.22	−$240K	59,992
2026-06-23	GLUEMonte Rosa Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−6,000 sh	—	—	96,000
2026-02-23	GLUEMonte Rosa Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−9,189 sh	$19.50	−$179K	65,837
2026-01-05	GLUEMonte Rosa Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−3,155 sh	$15.17	−$47.9K	75,026
2026-01-02	GLUEMonte Rosa Therapeutics, Inc.A Award	Chief Medical Officer	AAward	+31K sh	—	—	78,181
2026-01-02	GLUEMonte Rosa Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+139K sh	—	—	139,000
2025-01-02	GLUEMonte Rosa Therapeutics, Inc.A Award	Chief Medical Officer	AAward	+36K sh	—	—	45,189
2025-01-02	GLUEMonte Rosa Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+161K sh	—	—	161,000
2024-09-13	GLUEMonte Rosa Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+30K sh	—	—	30,000
2024-01-02	GLUEMonte Rosa Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+121K sh	—	—	121,000
2023-01-03	GLUEMonte Rosa Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+135K sh	—	—	135,000
2022-12-15	GLUEMonte Rosa Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+36K sh	—	—	36,000
2022-10-31	GLUEMonte Rosa Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+36K sh	—	—	36,000
2022-03-01	GLUEMonte Rosa Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+86.5K sh	—	—	86,500
2021-06-23	GLUEMonte Rosa Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+387K sh	—	—	387,069

Recent filings

Accepted (ET)
Jul 14
Janku Filip0001193125-26-292767
SEC(opens sec.gov)
Jun 304
Janku Filip0001193125-26-290486
SEC(opens sec.gov)
Jun 254
Janku Filip0001193125-26-282740
SEC(opens sec.gov)
Feb 244
Janku Filip0001193125-26-066955
SEC(opens sec.gov)
Jan 54
Janku Filip0001193125-26-002386
SEC(opens sec.gov)
Jan 64
Janku Filip0000950170-25-002102
SEC(opens sec.gov)
Sep 134
Janku Filip0000950170-24-106387
SEC(opens sec.gov)
Jan 44
Janku Filip0001209191-24-000764
SEC(opens sec.gov)

Companies

Monte Rosa Therapeutics, Inc.Chief Medical OfficerGLUE

Address

MONTE ROSA THERAPEUTICS, INC. 321 HARRISON AVENUE, SUITE 900

BOSTON, MA, 02118